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Abstract
Background. The study was performed to investigate the
prevalence,awarenessandtheriskfactorsofchronickidney
disease (CKD) in the community population in Shanghai,
China.
Methods. A total of 2596 residents were randomly re-
cruitedfromthecommunitypopulationinShanghai,China.
All were screened for albuminuria, haematuria, morning
spot urine albumin-to-creatinine ratio and renal function.
Serum creatinine, uric acid, cholesterol, triglyceride and
haemoglobin were assessed. A simplified MDRD equation
was used to estimate the glomerular filtration rate (eGFR).
All studied subjects were screened by kidney ultrasound.
Haematuria, if present in the morning spot urine dipstick
test,wasconfirmedbymicroscopy.Theassociationsamong
the demographic characteristics, health characteristics and
indicators of kidney damage were examined.
Results. Two thousand five hundred and fifty-four resi-
dents (n = 2554), after giving informed consent and with
complete data, were entered into this study. Albuminuria
and haematuria were detected in 6.3% and 1.2% of all
the studied subjects, respectively, whereas decreased kid-
ney function was found in 5.8% of all studied subjects.
Approximately 11.8% of subjects had at least one indi-
cator of kidney damage. The rate of awareness of CKD
was 8.2%. The logistic regression model showed that age,
central obesity, hypertension, diabetes, anaemia, hyperuri-
caemia and nephrolithiasis each contributed to the devel-
opment of CKD.
Conclusion. This is the first Shanghai community-based
epidemiological study data on Chinese CKD patients. The
prevalence of CKD in the community population in Shang-
hai is 11.8%, and the rate of awareness of CKD is 8.2%.
All the factors including age, central obesity, hypertension,
diabetes, anaemia, hyperuricaemia and nephrolithiasis are
positively correlated with the development of CKD in our
studied subjects.
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Introduction
Chronic kidney disease (CKD) is a common health prob-
lem imposing demand on healthcare service and cost to
the patients. The 2006 USRDS report indicated that the
number of cases of end-stage renal disease (ESRD) world-
wide had grown from 970 436 in 1999 to 1 172 655 in
2004, representing a 21% increase. In the USA, the ad-
justed rate for new cases of ESRD had reached 339 per
million population in 2004. The adjusted prevalence rate of
ESRD had surged to 1542 per million population in 2004
that was 5.4 times higher than that in 1980 and 1.4 times
higher than that in 1994 [1]. The total Medicare expendi-
ture for the ESRD in 2004, which was 18.5 billion USD,
16.3 billion USD were spent on the provision of dialysis
alone and the dialysis cost per patient year was reported
to be USD 66 650 [1]. In China, the prevalence rate of
ESRDwas33.16permillionpopulationin1999.Thepreva-
lence of ESRD in Shanghai in 1992 was 180 per million
population [2], but rose to 240 per million population in
2002 [3].
As healthcare resources are scarce, understanding its
prevalence, disease awareness and identification of the
early risk factors of CKD is mandatory and beneficial
in determining the most cost-effective strategies for the
prevention of ESRD. A few studies have demonstrated
that between 58.7% and 89.7% of CKD patients can be
detected earlier from the general population screening
[4,5].Ithasalsobeenwidelyacceptedthatearlyandregular
nephrology care will result in a decreased morbidity and
mortality, as well as improving the patients’ quality of life
[6]. Given the high prevalence and the low awareness of
CKD, it becomes inevitably necessary for many countries,
including China, to formulate appropriate strategies for the
prevention of the ESRD to control the escalating healthcare
cost. Since there can be a difference in the causative factors
leading to the development of the CKD in our community,
we undertook a community-based study on CKD subjects
in Shanghai from March to July 2006 to evaluate its
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prevalence and awareness among the general public and its
potential risk factors. We hope our study will allow us to
identify the appropriate interventional strategies towards
managing both the health costs and quality of life for CKD
patients more effectively and efficiently.
Material and methods
Study population
Shanghai is one of the most affluent cities in China with a total population
of about 19 million. It consists of eight districts of equally dense popula-
tions. Sampling came from a 3-stage study. First, the Changning district
was randomly selected. Secondly, a suburban area within the Changn-
ing district was assigned to this study. Thirdly, random blocks within
this suburban area with a reasonable number of residents (n = 2596
residents) were randomly recruited. The subjects studied must all have
resided in the Changning district for 6 months or more and be aged 18
years or older. A total of 2554 individuals who had completed data col-
lection were entered into the study. Among them, 911 were males and
1643 were females, aged between 18 and 104 years (median age 58.4 ±
15).
Screening protocol
The screening was conducted by the trained nephrologists and profes-
sional volunteers. After giving their informed consent, individuals com-
pleted a standardized questionnaire including information with regard to
their socio-demographic status (e.g. age, gender, education, occupation),
personal and family health history (e.g. hypertension, diabetes mellitus,
chronic kidney disease, cardiovascular disease, cerebrovascular disease
and tumours) and lifestyle habits (e.g. smoking, alcohol consumption).
Their height, weight, body mass index (BMI), waist circumference and
hip circumference were recorded. Blood pressures were measured as stip-
ulated in the guidelines of the Seventh Report of the Joint National Com-
mittee on Prevention, Detection, Evaluation and Treatment of High Blood
Pressure [7]. Fasting blood glucose and 2-h postpandrial glucose tests
were performed. The serum creatinine, uric acid, cholesterol, triglyc-
eride, haemoglobin as well as urinary albumin-to-creatinine ratio after
an overnight fast were also evaluated. Morning spot urine specimens were
collected to obtain the microalbumin-to-creatinine ratio. Also, positive
haematuria and pyuria morning spot urine dipstick results were confirmed
by microscopy. Kidney function was measured using the simplified Mod-
ification of Diet in Renal Disease (MDRD) equation to obtain estimated
glomerular filtration rate (eGFR). Nephrolithiasis was screened by ultra-
sound echogram of kidneys in all studied subjects.
Evaluation criteria
CKD was assessed based on the following: (1) the presence of the albu-
minuria, haematuria and pyuria, (2) eGRF and (3) morning spot urinary
microalbumin-to-creatinine ratio by dipstick (Bayer Diagnostics Manu-
facturing, Ltd).
Haematuria and pyuria were confirmed by urine microscopy for RBC
>3/HP and WBC >5/HP after excluding for urinary tract infection and
menstruation. Those who had haematuria or pyuria were to be tested again
in three months.
Elevated serum creatinine values were defined as eGFR (mL/min/
1.73 m2) that was calculated by the simplified MDRD equation:
eGFR = [186 × (serum creatinine − 1.154) × (age − 0.203)] [8].
However, for female study subjects, the calculated values were multiplied
by 0.742. If individuals’ eGFR was under <60 mL/min/1.73 m2,t h e y
were classified as having decreased kidney function. Also, the Kidney
Disease Outcomes Quality Initiative (K/DOQI) classification system was
employed to evaluate reduced kidney function based on eGFR for stage
1 disease (eGFR ≥90 mL/min) to stage 5 (eGFR <15 mL/min) [9].
The morning spot urinary microalbumin-to-creatinine ratio was ob-
tained by a half-quantization test as described above. Those who had a
positive morning spot urinary microalbuminuria dipstick test were to be
tested again three months later by a quantization test of the microalbumin-
to-creatinine ratio using the Unical DxC 800 auto-analyser (Beckman
Coulter Company). Only those positive at the baseline screening and
with individual urinary albumin-to-creatinine ratio >3.5 mg/mmol (for
males)and2.5mg/mmol(forfemales)3monthslaterwouldbeconsidered
positive.
Participants who currently required antihypertensive therapy to
control their blood pressure or those with a systolic blood pressure
(SBP) of 140 mmHg or greater and/or diastolic blood pressure (DBP)
of 90 mmHg or greater at screening had to be reconfirmed after a
third measurement (repeated every 15 min after rest) before they were
accepted as hypertensive [7]. Subjects with a diabetic history or those
with fasting blood glucose >7 mmol/L or 2-h postprandial blood glucose
>11 mmol/L were categorized as diabetic [10]. An equation [(weight
in kilograms)/(square of the height in meters)] was used to calculate the
BMI. BMI of 30 or greater was defined as obesity, and those between 25
and 30 were considered overweight [11]. Subjects had abdominal obesity
or central obesity if the waist-to-hip ratio was over 0.9 for males and 0.85
for females [11], or if the waist circumference was 102 cm or greater
for males and 88 cm or greater for females [12]. Aaemia was defined by
a haemoglobin <130 g/L for men and women older than 50 years and
<120 g/L for women 50 years or younger [13]. Those with serum choles-
terol >5.72 mmol/L and serum triglyceride >1.7 mmol/L at screening
were noted to have hypercholesteraemia and hypertriglyceridaemia,
respectively [14]. Those with serum uric acid of 420 µmol/L (males) and
of 360 µmol/L (females) at screening were considered hyperuricaemic
[15].
Statistical analysis
All the statistical data entering the EpiData 3.0 had an error checking
before the SPSS 11.50 analysis. Descriptive analyses were used to charac-
terize the participant population by sociodemographic data (e.g. age, gen-
der and education), health status (obesity, central obesity, hypertension,
diabetes, albuminuria, haematuria, pyuria, eGFR, urinary albumin-to-
creatinine, hypercholesteraemia, hypertriglyceridaemia, hyperuricaemia
and nephrolithiasis) and lifestyle factors (smoking, alcohol consumption).
Measurement data in mean and standard error were also presented. Nu-
meration data were analysed by the chi-square test. Multivariate analyses
were performed to assess the association of the screening demographic
and health characteristics with the presence of the urinary albumin-to-
creatinine ratio or decreased kidney function or CKD. A P-value < 0.05
was considered to be statistically significant.
Results
Demographic characteristics of the participants
Of 2596 individuals attending the screening programme,
only 2554 had completed the data entry (of which 911 were
males and 1643 were females). They ranged between 18
and 104 years, the mean age being 58.4 ± 15.3 years. A
total of 27.8% of participants (n = 710) were 50 years old
and younger. Most of the participants were well-educated
university graduates and students: 9.2% (n = 235); 18.7%
of participants (n = 478) were college graduates and stu-
dents: 18.7% (n = 478); secondary high school gradu-
ates and students: 53.1% (n = 1357). Eighty-six percent
of the participants had some form of health insurance.
Among all the 2554 participants, 53.1% had hyperten-
sion, 12.0% diabetes, 12.6% anaemia, 11.1% hypercholes-
terolaemia, 16.6% hypertriglyceridaemia, 9.8% hyperuri-
caemia, 4.8% gout and 2.2% had nephrolithiasis. In our
study, 7.05% (180/2554) of participants had an abnormal
waist-to-hip ratio, 30.2% (772/2554) of participants were
overweight while 4.6% (118/2554) were obese, and abnor-
mal waist circumference was present in 14.4% of 2554
participants.Community-based study of CKD in Shanghai 2119
Among all hypertensive subjects, 80.2% noted that they
had hypertension but only 53% of all the hypertensives
received antihypertensive therapy. However, 9.7% of all the
hypertensive subjects had albuminuria but only 8.8% of all
hypertensive subjects also had decreased kidney function.
Diabetes awareness was 76.1% among all studied subjects
but only 64.7% of them had treatment. Of those diabetics,
only 14.7% had albuminuria, 11.1% had decreased kid-
ney function. Nephrolithiasis was detected in 56 subjects
but over 65% of them were males. A total of 14.3% of
nephrolithiasisparticipantshadalbuminuriabutonly14.3%
had decreased kidney function.
Kidney damage
Kidney damage was evaluated depending upon whether
there was the presence or the absence of albumin-
uria, haematuria, decreased kidney function and urinary
albumin-to-creatinine ratio. Routine urinalysis at baseline
showed that 8.9% of the participants (n = 228) tested
postive, including 2.0% (n = 52) with proteinuria, 1.2%
(n = 30) with haematuria and 5.7% (n = 146) with pyuria.
Three months later, 228 participants with abnormal urinal-
ysis at baseline screening should have been retested again,
but only 86.8% attended (n = 198). At the follow-ups,
the incidence of an abnormal urinary finding dropped to
3.1%, including 1.2%, 1.2% and 0.7% for those with ini-
tial proteinuria, haematuria and pyuria, respectively. There
was no difference between males and females in haema-
turia (P > 0.05), but there was a significant difference be-
tween males and females in pyuria (P < 0.01) and there
was clearly a much higher prevalence in females with
pyuria.
In the half-quantization of the urinary albumin-to-
creatinine ratio test (ACR), 18.7% of the participants
(n = 478) were positive, and 93% (n = 444) of them were
tested again by the quantization of ACR. Of all partici-
pants, 6.3% (n = 161) had albuminuria. Of these albu-
minuria participants, 80% (n = 129) had a hypertensive
history. Of all albuminuria participants, 28% (n = 45) had
diabetes.
Among all the participants, 5.8% (n = 149) had de-
creased kidney function of which 140 participants had
an eGFR between 30 and 59.9 mL/min/1.73 m2, eight
with an eGFR between 15 and 29.9 mL/min/1.73 m2 and
one with an eGFR <15 mL/min/1.73 m2. However, if the
decreased kidney function were defined by the elevated
serum creatinine >115 µmol/l, the prevalence of the de-
creased kidney function would reduce to 2.4%. In the
renal morphological examination, among all the studied
subjects, 9.0% (n = 231) had renal cysts. Of these, 2.2%
(n = 56) had nephrolithiasis and 1.8% (n = 46) had other
abnormalities (e.g. hamartoma, double pelvic and polycys-
tic kidney).
The prevalence of CKD
In accordance with the guidelines of the Kidney Disease
Outcome Quality Initiative set out by the National Kidney
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Fig. 1. Biomeasures of renal disease in the current study.
Foundation in 1999 [9], CKD takes place in the presence of
albuminuria,haematuriaandthedecreasedkidneyfunction.
A total of 11.8% of our studied subjects (n = 302) had
CKD, of which 2.4% were at stage 1, 3.6% at stage 2, 5.5%
at stage 3, 0.3% at stage 4 and 0.04% at stage 5 (Figure 1
and Table 1). In our study, the most common community
subjects studied fall at the CKD stage 3 category.
A total of 302 participants with CKD were identified,
of which, 98 were males and 204 were females. The CKD
prevalence for our male subjects was 10.8% and 12.4% for
females, but there was no significant difference between
them (P > 0.05). Our CKD participants were aged from 10
to 104 years, an average of 68.9 ± 13.2 years. The CKD
prevalencewas0.9%forthegroupof18–29yearsold,4.6%
for30–39yearsold,5.1%for40–49yearsold,7.6%for50–
59 years old, 9.9% for 60–69 years old, 22.9% for 70–79
years old and 37.1% for 80 years old and above (Table 2).
A significant statistical difference was noted among every
age group (P < 0.01), and obviously as the age advances,
the CKD prevalence also rises.
Multivariate analyses
The logistic multiple regression analysis in our community
study demonstrated that the following were the risk factors
of CKD: (1) age (OR = 1.062, P < 0.001); (2) central
obesity(OR=1.631,P=0.045);(3)anaemia(OR=2.745,
P < 0.001); (4) hypertension (OR = 1.463, P = 0.037); (5)
diabetes(OR=1.970,P<0.001);(6)hyperuricaemia(OR
= 3.084, P < 0.001) and (7) nephrolithiasis (OR = 2.922,
P = 0.018) (Table 3).
Likewise, for the development of albuminuria, we found
that all the following were risk factors, namely hyperten-
sion (OR = 1.972, P = 0.014), diabetes (OR = 2.139,
P = 0.004), anaemia (OR= 2.093, P = 0.007) and cerebral
vascular accident (CVA) (OR = 1.918, P = 0.043).
Also it was shown that age (OR = 1.090, P < 0.001), hy-
pertension(OR=1.012,P=0.039),anaemia(OR=2.398,
P < 0.001), gout (OR = 1.892, P = 0.033), nephrolithiasis
(OR = 2.615, P = 0.049), hyperuricaemia (OR = 4.976,
P < 0.001) and albuminuria (OR = 2.301, P = 0.002) were2120 N. Chen et al.
Table 1. Distribution of decreased kidney function and CKD among the surveyed community population
Decreased kidney function CKD
Total number of Prevalence (%) Number of Number of Number of Prevalence (%)
participants participants with
albuminuria at
participants with
continuous
participants
MDRD-eGFR baseline screening albuminuria at the
(mL/min/1.73 m2) repeated test
≥90 1189 46.6 188 49 61 2.4
60–89.9 1216 47.6 237 79 92 3.6
30–59.9 140 5.5 53 27 140 5.5
15–29.9 8 0.3 8 5 8 0.3
<15 1 0.04 1 1 1 0.04
Total 2554 100 487 161 302 11.8
Table 2. Distribution of the community CKD participants in various age
groups
18–29 30–39 40–49 50–59 60–69 70–79 80–104
Stage 1 1.5% 7.5% 16.4% 29.9% 14.9% 22.4% 7.5%
Stage 2 0.0% 1.0% 7.8% 22.3% 14.6% 42.7% 11.7%
Stage 3 0.0% 0.7% 2.9% 5.7% 11.4% 52.1% 27.1%
Stage 4 0.0% 0.0% 0.0% 0.0% 0.0% 50.0% 50.0%
Stage 5 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 0.0%
Total 0.9% 4.6% 5.1% 7.6% 9.9% 22.9% 37.1%
the risk factors for the development of decreased kidney
function.
The awareness of CKD
Among all the community CKD participants, 38.4%
(n = 116) had never had a urinary test before and 94.7%
(n = 286) never had a serum creatinine test before. Among
all, only 25 participants had a history of kidney damage
of which 11 had decreased kidney function, 5 had chronic
nephritis, 1 had polycystic renal disease, 1 had a transplant
kidney, 6 had proteinuria and 1 had haematuria. Hence,
the awareness of CKD among the CKD participants was
8.2% and there was no difference between males and
females (P > 0.05). Most were well educated but no
significant difference was detected among the different
levels of education (P > 0.05). The awareness of stage 1–5
CKD was 4.5%, 8.7%, 7.1%, 37.5%, 100%, respectively,
but statistically significant among all five different stages
(P < 0.01). Apparently, deteriorated renal function with
symptomatic manifestation did raise the awareness of
CKD in our studied subjects. Participants with a family
history of CKD also had an increased awareness (22.2%)
compared to those without a family history of CKD
(7.3%). The difference between the two groups aforesaid
was statistically significant (P < 0.01). The awareness
of CKD of those with comorbidity (e.g. hypertension,
diabetes,cardiovasculardisease,cerebralvascularaccident)
was 2.0% as compared with those without comorbidity
(0.3%). Again, there was a significant difference between
the two groups mentioned above (P < 0.01), but there
was no difference among the type of comorbid disease
(P > 0.05).
Discussion
This is the first study in Shanghai on surveillance of com-
munity CKD patients. However, before this study, little was
Table 3. The logistic multiple regression analysis of the risk factors of community CKD
Risk factors Coefficient of regression Standard error Chi-square value OR P-value
Age 0.060 0.005 137.533 1.062 <0.001
Male 0.258 0.134 3.725 1.295 0.054
Overweight −0.071 0.206 0.120 0.931 0.729
Obesity −0.338 0.369 0.841 0.713 0.359
Central obesity 0.489 0.243 4.036 1.631 0.045
Waist-to-hip ratio 0.222 0.191 1.351 1.249 0.245
Hypertension 0.381 0.183 4.335 1.463 0.037
Diabetes 0.678 0.212 10.273 1.970 0.001
Anaemia 1.010 0.199 25.686 2.745 <0.001
Hypertriglyceridaemia 0.099 0.204 0.238 1.105 0.626
Hyperuricaemia 1.126 0.229 24.217 3.084 <0.001
Nephrolithiasis 1.072 0.455 5.558 2.922 0.018
Gout 0.472 0.331 2.037 1.604 0.154
Cerebral vascular accident 0.254 0.271 0.877 1.289 0.349
Cardiovascular disease −0.003 0.191 0.000 0.997 0.989Community-based study of CKD in Shanghai 2121
known about the prevalence, disease awareness and its risk
factors leading to the development of CKD in Shanghai.
Our primary objective is to examine the CKD prevalence
in Shanghai, which has about 20 million inhabitants, the
disease awareness and its potential risk factors that will
lead to CKD in the public. Our secondary objective is to
detect the earlier cases of the CKD and those populations
at high risk of developing CKD. Our third objective is,
of course, to determine the most appropriate management
strategiestoimprovetheprognosisofourCKDpatientpop-
ulation in Shanghai and ultimately improve their quality of
life.
The epidemiological screening of the population in
Beijing, examining only those aged 40 and above, revealed
a 9.4% prevalent rate of CKD [16]. In this study, our
studied subjects ranged from the age of 18 to 104 years
and 10.3% of our studied subjects were <40 years old.
After studying 2554 adult participants randomly, it is clear
that the prevalence of community CKD in Shanghai is
11.8%,whichisverysimilartotherecentsurveyinAmerica
[17]. The prevalence of CKD in Australia, by testing albu-
min and serum creatinine, is 16% among those aged 25
years and older [18].
In our study, we used the staging of CKD recommended
by KDOQI to categorize all the participants with kidney
damage.However,itwasproposedrecentlythatstages1and
2 of CKD should be eliminated because they did not reflect
theseverityandcomplicationsofCKDaccuratelyinelderly
people [19]. As the definition of CKD in elderly patients
is controversial, further study is necessary to evaluate the
staging of CKD in those populations.
In China, nephritis followed by diabetic nephropathy has
been well documented as the second most leading cause of
theCKD[3].Hence,theindicatorsthatweusedinthisstudy
toscreenforthekidneydamageevidencewerealbuminuria,
haematuria and decreased kidney function.
Examining albuminuria in the routine analysis, in our
view, is not only a relatively simple, non-invasive and cost
effective measure to give the qualitative and quantitative
assessment of the early stage of CKD, and to reveal those
at high risk of developing CKD, but also is informative in
the prediction of hypertension, diabetes and cardiovascu-
lar disease [20]. We re-examined all our participants three
months later if their baseline urinalysis was positive at
screening. A total of 94.6% of those with albuminuria and
86.8% of those with haematuria or pyuria at the baseline
screeningundertooktheirrepeatedurinalysis.Resultsshow
that the prevalence of proteinuria is 1.2% in our study. In
Singapore, the prevalence of proteinuria is 1.1% [5]. In our
study, the prevalence of albuminuria is 6.3% by the uri-
nary albumin-to-creatinine ratio. In America [17] and the
Dutch PREVEND study, the prevalence of albuminuria is
9.3% and 7.2% by the urinary albumin-to-creatinine ratio,
respectively. In Japan, it is 4.7% and 3.5% for males and fe-
males,respectively[22].Obviously,theurinaryalbumin-to-
creatinine ratio could improve the detection rate and reduce
the rate of misdiagnosis.
The K/DIGO guidelines also recommended examining
the urinary albumin-to-creatinine ratio as the best index
for the evidence of the early vascular endothelial injury
[23]. In our study, the prevalence of the urinary albumin-
to-creatinine ratio is 6.3% compared to 7.2% reported in
the PREVEND study [21].
Our result shows that the prevalence of haematuria is
1.2% as compared with the 4.7% being reported in the
AusDiab survey [18]. The prevalence of pyuria in our
study is 0.7%. We did exclude urinary infection or uri-
nary stones in subjects with pyuria to avoid false positive
interpretation.
Serum creatinine has been widely used to measure indi-
vidual renal function but its assessment can be affected by
age, gender, racial difference and GFR. Because our kid-
neys have a powerful compensatory function, serum crea-
tinine will only begin to cripple up when our renal function
has>50%deterioration.Hence,manystage3CKDpatients
do not necessarily have an abnormally high serum creati-
nine level. If the decreased kidney function is defined by
the presence of the serum creatinine reaching 115 µmol/L,
then we could only identify a 2.4% prevalence of the de-
creased kidney function in our study. We feel that mea-
surement of the serum creatinine alone as the only criteria
for the CKD diagnosis may be misleading. Hence, in this
study, we detected the prevalent rate of decreased kidney
functionat5.8%afterusingthesimplifiedMDRDequation
whereas6.8%and11.2%havebeenreportedintheUSAand
Australia, respectively.
In our survey, it was shown that several clinical vari-
ables were associated with CKD. Those variables include
hyperuricaemia, nephrolithiasis, anaemia, diabetes, central
obesity,hypertensionandage.Ageinghasbeendescribedas
a non-regulatory factor for the development of CKD [24].
It has also been universally recognized to be in positive
association with an arterial atherosclerotic change.
In recent years [25–27], excessive abdominal fat (central
obesity) has made more hazards to health than the fatty
bottom and limbs. Now it is generally accepted that the
waist circumference is the most simple and practical in-
dicator to measure abdominal fat. The level of abdominal
fat is an independent risk factor predictor of many dis-
eases. It is more sensitive than the waist-to-hip ratio in
estimating the abdominal fat. Our survey showed that el-
evated waist circumference is a risk factor for the devel-
opment of CKD. Also, its prevalence is high at 14.4%. It
is not related to general obesity, overweight and elevated
waist-to-hip ratio. This is different from that observed in
other countries [28]. It may be that the cause is of eth-
nic origin. It also showed that central obesity is related
not only to diabetes and cardiovascular disease but also to
CKD.
The K/DOQI guidelines include the imaging examina-
tion in the definition of CKD. First we perform renal ultra-
sound examination in the epidemiological screening. In our
study, the prevalence of renal cysts is 9.0%. At the same
time, the prevalence of nephrolithiasis is higher in CKD
patients (5.6%) than in non-CKD patients (1.7%). This is
similar to the results being reported in America [29]. Also
in other studies, nephrolithiasis has been documented as a
risk factor for the development of CKD [30,31]. In 3.0%
patients, ESRD was caused by nephrolithiasis. In China,
the cause of nephrolithiasis is mainly due to dietary in-
take [32]. The formation of calculus will be reduced by
adjusting the diet structure. Then reducing prevalence of2122 N. Chen et al.
nephrolithiasis might be helpful to reduce prevalence of
CKD. We first concentrate on the nephrolithiasis in the epi-
demiological screening. It will be further observed in the
subsequent study. As the renal ultrasound examination is
simple, non-invasive and of low cost, we think that it could
be applied to the epidemiological screen of CKD to scree
for nephrolithiasis.
In our study, hyperuricaemia is associated with CKD.
In the studies published elsewhere, hyperuricaemia was re-
ported to be a risk factor for the development of CKD and
elevated levels of uric acid independently increase the risk
fornew-onsetkidneydisease[33–35].AsCKDcouldcause
elevatedlevelsofuricacidwhilehyperuricaemiacouldalso
contribute to the progression of CKD, the predictive value
ofhyperuricaemiainCKDneedsfurtherstudy.Earlierman-
agement of the anaemia has been documented to retard the
development of CKD [36]. Our study shows that anaemia
is another variable associated with CKD.
Some studies suggest that it is more cost-effective to
screenamongthehigh-riskpopulationthanamongthegen-
eralpopulation[33].However,wefindthattheriskfactorof
CKD among the Chinese population is different from that
in the USA and Europe. Maybe it is related to the spectrum
of disease, race, diet and living habits. Therefore, we could
not simply assume the risk factors of CKD among the US
peopletobethesameasamongtheChinesepopulation.Itis
necessarytoscreenamongthegeneralpopulationinChina.
TheawarenessofCKDintheUSislow[37].Inourstudy,
many patients with CKD have fewer clinical symptoms,
which perhaps helps to explain why the disease awareness
of CKD is low in spite of high prevalence rates, but this
could be tested by regular laboratory examination. Even if
we already have a simple test to detect the early stage of
CKD, it has not been widely used clinically. Even if the
participants had a health examination, half of them did not
havearegularurinetest.TheawarenessofCKDisincreased
withthedeclineinrenalfunction,thedevelopmentofCKD,
complicated by hypertension, diabetes and cardiovascular
disease.
In conclusion, the prevalence of CKD is 11.8% among
the community population in Shanghai. It is 2.4%, 3.6%,
5.5%, 0.3% and 0.04% in stages 1–5, respectively. As it is
more prevalent in the early stage of CKD in America, we
shouldconcentrateontheearlystagesofCKDinepidemio-
logicalsurveyandyoungpeople.Alsothepopulationshows
decreased kidney function by the MDRD equation with a
normalurinetest.Thescreeningwaseffectiveinidentifying
the CKD population and high-risk CKD population.
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Abstract
Background. Available data indicate that serum phosphate
increases only when glomerular filtration rate (GFR) falls
into the low range (<60 mL/min × 1.73 m2). GFR and
serum phosphate decrease with ageing. This population-
based study investigated by age-controlled analyses the re-
lationshipofGFRwithserumphosphateinadultswithGFR
above the low range.
Methods.Datawerecollectedonage,sex,menstrualstatus,
anthropometry,overnighturinarycreatinine,dietaryprotein
(overnight urinary urea), reported intake of milk/yogurt,
serum creatinine, phosphate, calcium and total protein in
4034 adults (age 18–91 years) with GFR ≥60 mL/min ×
1.73 m2 as assessed by estimated GFR (eGFR, simplified
MDRD equation) and creatinine clearance (overnight uri-
nary creatinine/serum creatinine).
Results. The relationship of eGFR with serum phos-
phate was positive in men and null in women in uni-
variate analyses (P = 0.001 and 0.148), negative in both
sexes with age adjustment (P < 0.001). Age-adjusted
results did not depend on colinearity between age and
eGFR because the relationship was inverse also replac-
ing eGFR with creatinine clearance (P < 0.001 in both
sexes). In univariate regression analysis done separately
by gender and six age-strata (18–24, 25–34, 35–44, 45–
54, 55–64 and ≥65), the line of serum phosphate over
eGFR was constantly inverse (range of P = 0.010/0.089)
with the progressively lower y-axis intercept from young
to older ages. The inverse relationship of eGFR or
creatinine clearance with serum phosphate was signifi-
cantly inverse also controlling for other variables (P <
0.01).
Conclusions. GFR differences in the range ≥60 mL/min ×
1.73 m2 are inversely and independently related to serum
phosphate. The relationship is undetectable without age-
controlled procedures because, for serum phosphate, the
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